BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8564084)

  • 1. Use of a renal tubule cell line (LLC-PK1) to study the nephrotoxic potential of a kappa-type Bence-Jones protein.
    Diemert MC; Tricottet V; Benel L; Descamps G; Escolano E; Galli J; Reynès M; Rousselet F
    In Vitro Cell Dev Biol Anim; 1995 Oct; 31(9):716-23. PubMed ID: 8564084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does catalytic activity of Bence-Jones proteins contribute to the pathogenesis of multiple myeloma?
    Sinohara H; Matsuura K
    Appl Biochem Biotechnol; 2000; 83(1-3):85-92; discussion 93-4, 145-53. PubMed ID: 10826951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship between the catalysis of Bence Jones protein and renal impairment in patients with multiple myeloma].
    Zhou X; Zhai YP; Mei JG; An ZM; Zhou XG; Shi P; Yu YP; Liu HN; Song P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Apr; 20(2):339-43. PubMed ID: 22541094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Catalytic activity of Bence Jones proteins in renal impairment of patients with multiple myeloma - review].
    Zhou X; Zhai YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):796-800. PubMed ID: 22739205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal tubular lesions induced by human Bence Jones protein in the rat: N-acetyl-beta-D-glucosaminidase as a sensitive marker.
    Yokota N; Yamamoto Y; Kitamura K; Kuroki N; Hisanaga S; Fujimoto S; Eto T; Tanaka K
    Int J Exp Pathol; 1991 Jun; 72(3):255-62. PubMed ID: 1843254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenicity of catalytic antibodies: catalytic activity of Bence Jones proteins from myeloma patients with renal impairment can elicit cytotoxic effects.
    Matsuura K; Ohara K; Munakata H; Hifumi E; Uda T
    Biol Chem; 2006 May; 387(5):543-8. PubMed ID: 16740125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catalytic activities and functional effects of Bence Jones proteins.
    Sinohara H; Matsuura K
    Chem Immunol; 2000; 77():89-101. PubMed ID: 11706708
    [No Abstract]   [Full Text] [Related]  

  • 8. Nephrotoxic potential of Bence Jones proteins.
    Solomon A; Weiss DT; Kattine AA
    N Engl J Med; 1991 Jun; 324(26):1845-51. PubMed ID: 1904132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential nephrotoxicity of low molecular weight proteins including Bence Jones proteins in the perfused rat nephron in vivo.
    Sanders PW; Herrera GA; Chen A; Booker BB; Galla JH
    J Clin Invest; 1988 Dec; 82(6):2086-96. PubMed ID: 3198767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Bence Jones protein toxicity in rat proximal tubule epithelium in vivo.
    Sanders PW; Herrera GA; Galla JH
    Kidney Int; 1987 Dec; 32(6):851-61. PubMed ID: 3123760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Albumin in the mg/l-range activates NF-kappaB in renal proximal tubule-derived cell lines via tyrosine kinases and protein kinase C.
    Drumm K; Gassner B; Silbernagl S; Gekle M
    Eur J Med Res; 2001 Jun; 6(6):247-58. PubMed ID: 11432793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Na superset+/H superset+ exchange decreases albumin-induced NF-kappaB activation in renal proximal tubular cell lines (OK and LLC-PK1 cells).
    Drumm K; Gassner B; Silbernagl S; Gekle M
    Eur J Med Res; 2001 Oct; 6(10):422-32. PubMed ID: 11698229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced glycated albumin impairs protein degradation in the kidney proximal tubules cell line LLC-PK1.
    Sebeková K; Schinzel R; Ling H; Simm A; Xiang G; Gekle M; Münch G; Vamvakas S; Heidland A
    Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1051-60. PubMed ID: 9846887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cardiac glycosides on sodium pump expression and function in LLC-PK1 and MDCK cells.
    Liu J; Periyasamy SM; Gunning W; Fedorova OV; Bagrov AY; Malhotra D; Xie Z; Shapiro JI
    Kidney Int; 2002 Dec; 62(6):2118-25. PubMed ID: 12427136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of dedifferentiated clones of LLC-PK1 cells upon long-term exposure to dichlorovinylcysteine.
    Vamvakas S; Richter H; Bittner D
    Toxicology; 1996 Jan; 106(1-3):65-74. PubMed ID: 8571403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some Bence-Jones proteins enter cultured renal tubular cells, reach nuclei and induce cell death.
    Matsuura K; Ikoma S; Watanabe M; Togawa A; Sinohara H
    Immunology; 1999 Dec; 98(4):584-9. PubMed ID: 10594692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the novel HK-2 human renal proximal tubular cell line with the standard LLC-PK1 cell line in studying drug-induced nephrotoxicity.
    Gunness P; Aleksa K; Kosuge K; Ito S; Koren G
    Can J Physiol Pharmacol; 2010 Apr; 88(4):448-55. PubMed ID: 20555413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of uranium(VI) speciation for the evaluation of in vitro uranium cytotoxicity on LLC-PK1 cells.
    Mirto H; Barrouillet MP; Hengé-Napoli MH; Ansoborlo E; Fournier M; Cambar J
    Hum Exp Toxicol; 1999 Mar; 18(3):180-7. PubMed ID: 10215109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrotoxicity of human Bence Jones protein in rats: proteinuria and enzymuria profile.
    Prado MJ; Nicastri AL; Leo P; Uchino E; Sesso A; Marcondes M; Prado EB
    Braz J Med Biol Res; 1993 Jun; 26(6):633-8. PubMed ID: 8257949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased cellular toxicity of neomycin in a clonal cell line isolated from LLC-PK1.
    Hori R; Okuda M; Ohishi Y; Yasuhara M; Inui K; Takano M
    Pharm Res; 1993 Apr; 10(4):573-6. PubMed ID: 8097873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.